1576. Re-Evaluation of cefepime or piperacillin-tazobactam to Decrease Use of Carbapenems in ESBL-Producing Enterobacterales BloodStream Infections (REDUCE-BSI)

BACKGROUND: The ideal therapy for treatment of bloodstream infections (BSI) due to ESBL-producing organisms is widely debated. Although prior studies have demonstrated efficacy of non-carbapenems (CBPNs) for ESBL infections, results from the MERINO study group found increased mortality associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Catherine H, Venugopalan, Veena, Santevecchi, Barbara A, Voils, Stacy A, Cherabuddi, Kartikeya, DeSear, Kathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777247/
http://dx.doi.org/10.1093/ofid/ofaa439.1756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777247/
http://dx.doi.org/10.1093/ofid/ofaa439.1756

Ejemplares similares